Abstract
Introduction: Obesity is a well-known risk factor for a variety of gastrointestinal disorders (GID). Helicobacter pylori is associated with different GID, such as gastric cancer and chronic gastritis. In this study, we investigated the prevalence of dominant genotypes in H. pylori isolated from obese patients diagnosed with gastric ulcer, duodenal ulcer, and gastric cancer. Methods: A total of 222 H. pylori-positive samples were collected from patients with obesity. GID and gastric cancer were identified by endoscopy and histopathology, respectively. Three biopsy specimens from the gastric antrum were obtained from each patient for culture tests, histological examination, and identification of vacuolating cytotoxin A (vacA) (vacA s1, vacA s2, vacA m1, vacA m2, vacA s1m1 vacA s1m2, vacA s2m1, and vacA s2m2), cagA, cagE, iceA1, oipA, dupA, and babA2 using polymerase chain reaction. Results: vacA, cagE, cagA, iceA1, oipA, dupA, and babA2 genes were detected in 222 (100%), 171 (77%), 161 (72.5%), 77 (34.6%), 77 (34.6%), 137 (61%), and 69 (31%) patients with obesity, respectively. Our findings revealed that vacA, iceA1, oipA, and babA2 were significantly associated with a higher risk of GID, while cagE, cagA, and dupA indicated no correlation with the development of GID. Also, in the combination of s- and m-region genotypes, s1m2 (79%) was the most frequently identified genotype in patients with obesity. A significant association was also found between cagA and the presence of vacA genotypes (except for vacA m1 and babA2). Conclusions: This study indicated the high prevalence of different virulence genes in H. pylori isolated from obese patients and supported the significant role of H. pylori in the development of GID.
References
1.
Tabasi
M
, Eybpoosh
S
, Siadat
SD
, Elyasinia
F
, Soroush
A
, Bouzari
S
. Modulation of the gut microbiota and serum biomarkers after laparoscopic sleeve gastrectomy: a 1-year follow-up study
. Obes Surg
. 2021
;31
(15
):1
–8
.2.
Tabasi
M
, Eybpoosh
S
, Sadeghpour Heravi
F
, Siadat
SD
, Mousavian
G
, Elyasinia
F
, Gut microbiota and serum biomarker analyses in obese patients diagnosed with diabetes and hypothyroid disorder
. Metab Syndr Relat Disord
. 2021 Apr
;19
(3
):144
–51
.3.
Tabasi
M
, Anbara
T
, Siadat
SD
, Kheirvari Khezerloo
J
, Elyasinia
F
, Bayanolhagh
S
, Socio-demographic characteristics, biochemical and cytokine levels in bulimia nervosa candidates for sleeve gastrectomy
. Arch Iran Med
. 2020
;23
(1
):23
–30
.4.
Kheirvari
M
, Dadkhah Nikroo
N
, Jaafarinejad
H
, Farsimadan
M
, Eshghjoo
S
, Hosseini
S
, The advantages and disadvantages of sleeve gastrectomy; clinical laboratory to bedside review
. Heliyon
. 2020
;6
(2
):e03496
. .5.
Keren
D
, Matter
I
, Rainis
T
, Goldstein
O
, Stermer
E
, Lavy
A
. Sleeve gastrectomy leads to Helicobacter pylori eradication
. Obes Surg
. 2009
;19
(6
):751
–6
. .6.
Tabasi
M
, Ashrafian
F
, Khezerloo
JK
, Eshghjoo
S
, Behrouzi
A
, Javadinia
SA
, Changes in gut microbiota and hormones after bariatric surgery: a bench-to-bedside review
. Obes Surg
. 2019
;29
(5
):1663
–74
. .7.
Farsimadan
M
, Motamedifar
M
. Bacterial infection of the male reproductive system causing infertility
. J Reprod Immunol
. 2020
;142
:103183
. .8.
Brownlee
AR
, Bromberg
E
, Roslin
MS
. Outcomes in patients with Helicobacter pylori undergoing laparoscopic sleeve gastrectomy
. Obes Surg
. 2015
;25
(12
):2276
–9
. .9.
Kao
CY
, Sheu
BS
, Wu
JJ
. Helicobacter pylori infection: an overview of bacterial virulence factors and pathogenesis
. Biomed J
. 2016
;39
(1
):14
–23
. .10.
Chen
LW
, Kuo
SF
, Chen
CH
, Chien
CH
, Lin
CL
, Chien
RN
. A community-based study on the association between Helicobacter pylori Infection and obesity
. Sci Rep
. 2018
;8
(1
):10746
–10
. .11.
Xu
X
, Li
W
, Qin
L
, Yang
W
, Yu
G
, Wei
Q
. Relationship between Helicobacter pylori infection and obesity in Chinese adults: a systematic review with meta-analysis
. PLoS One
. 2019
;14
(9
):e0221076
.12.
Abdullahi
M
, Annibale
B
, Capoccia
D
, Tari
R
, Lahner
E
, Osborn
J
, The eradication of Helicobacter pylori is affected by body mass index (BMI)
. Obes Surg
. 2008
;18
(11
):1450
–4
. .13.
Renshaw
AA
, Rabaza
JR
, Gonzalez
AM
, Verdeja
JC
. Helicobacter pylori infection in patients undergoing gastric bypass surgery for morbid obesity
. Obes Surg
. 2001
;11
(3
):281
–3
. .14.
Graham
DY
. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits
. Gastroenterology
. 2015
;148
(4
):719
–e3
. .15.
Costa
AC
, Figueiredo
C
, Touati
E
. Pathogenesis of Helicobacter pylori infection
. Helicobacter
. 2009
;14
:15
–20
. .16.
Peek
RM
Jr, Crabtree
JE
. Helicobacter infection and gastric neoplasia
. J Pathol
. 2006
;208
(2
):233
–48
. .17.
Palframan
SL
, Kwok
T
, Gabriel
K
. Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis
. Front Cell Infect Microbiol
. 2012
;2
:92
. .18.
Boncristiano
M
, Paccani
SR
, Barone
S
, Ulivieri
C
, Patrussi
L
, Ilver
D
, The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms
. J Exp Med
. 2003
;198
(12
):1887
–97
. .19.
Jones
KR
, Cha
JH
, Merrell
DS
. Who’s winning the war? Molecular mechanisms of antibiotic resistance in Helicobacter pylori
. Curr Drug ther
. 2008
;3
(3
):190
–203
. .20.
Latifi-Navid
S
, Ghorashi
SA
, Siavoshi
F
, Linz
B
, Massarrat
S
, Khegay
T
, Ethnic and geographic differentiation of Helicobacter pylori within Iran
. PloS One
. 2010
;5
(3
):e9645
. .21.
Wu
Q
, Qin
K
, Wang
Y
. Central obesity is associated with Helicobacter pylori infection: a large-scale cross-sectional retrospective study in West China
. Int J Diabetes Dev Ctries
. 2019
:1
–9
.22.
Wen
S
, Velin
D
, Felley
CP
, Du
L
, Michetti
P
, Pan-Hammarström
Q
. Expression of Helicobacter pylori virulence factors and associated expression profiles of inflammatory genes in the human gastric mucosa
. Infect Immun
. 2007
;75
(11
):5118
–26
. .23.
den Hollander
WJ
, Broer
L
, Schurmann
C
, Meyre
D
, den Hoed
CM
, Mayerle
J
, Helicobacter pylori colonization and obesity: a Mendelian randomization study
. Sci Rep
. 2017
;7
(1
):14467
–7
. .24.
Feliciano
O
, Gutierrez
O
, Valdés
L
, Fragoso
T
, Calderin
AM
, Valdes
AE
, Prevalence of Helicobacter pylori vacA, cagA, and iceA genotypes in Cuban patients with upper gastrointestinal diseases
. Biomed Res Int
. 2015
;2015
:753710
. .25.
Aziz
F
, Chen
X
, Yang
X
, Yan
Q
. Prevalence and correlation with clinical diseases of Helicobacter pylori cagA and vacA genotype among gastric patients from Northeast China
. Biomed Res Int
. 2014
;2014
:142980
. .26.
Wei
GC
, Chen
J
, Liu
AY
, Zhang
M
, Liu
XJ
, Liu
D
, Prevalence of Helicobacter pylori vacA, cagA and iceA genotypes and correlation with clinical outcome
. Exp Ther Med
. 2012
;4
(6
):1039
–44
. .27.
Vinagre
ID
, Queiroz
AL
, Silva Júnior
MR
, Vinagre
RM
, Martins
LC
. Helicobacter pylori infection in patients with different gastrointestinal diseases from northern Brazil
. Arq Gastroenterol
. 2015
;52
(4
):266
–71
. .28.
Pajavand
H
, Alvandi
A
, Mohajeri
P
, Bakhtyari
S
, Bashiri
H
, Kalali
B
, High frequency of vacA s1m2 genotypes among Helicobacter pylori isolates from patients with gastroduodenal disorders in Kermanshah, Iran
. Jundishapur J Microbiol
. 2015
;8
(11
):e25425
. .29.
Biernat
MM
, Gościniak
G
, Iwańczak
B
. Prevalence of Helicobacter pylori cagA, vacA, iceA, babA2 genotypes in Polish children and adolescents with gastroduodenal disease
. Postepy Hig Med Dosw
. 2014
;68
:1015
. .30.
Abu-Taleb
AMF
, Abdelattef
RS
, Abdel-Hady
AA
, Omran
FH
, El-Korashi
LA
, Abdel-aziz El-hady
H
, Prevalence of Helicobacter pylori cagA and iceA genes and their association with gastrointestinal diseases
. Int J Microbiol
. 2018
;2018
:1
. .31.
Román-Román
A
, Martínez-Carrillo
DN
, Atrisco-Morales
J
, Azúcar-Heziquio
JC
, Cuevas-Caballero
AS
, Castañón-Sánchez
CA
, Helicobacter pylori vacA s1m1 genotype but not cagA or babA2 increase the risk of ulcer and gastric cancer in patients from Southern Mexico
. Gut Pathog
. 2017
;9
(1
):18
. .32.
Souod
N
, Sarshar
M
, Dabiri
H
, Momtaz
H
, Kargar
M
, Mohammadzadeh
A
, The study of the oipA and dupA genes in Helicobacter pylori strains and their relationship with different gastroduodenal diseases
. Gastroenterol Hepatol Bed Bench
. 2015
;8
(Suppl 1
):S47
.© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
